These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37428815)

  • 1. Impact of preventive chemotherapy on Strongyloides stercoralis: A systematic review and meta-analysis.
    Stroffolini G; Tamarozzi F; Fittipaldo A; Mazzi C; Le B; Vaz Nery S; Buonfrate D
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011473. PubMed ID: 37428815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need.
    Bisanzio D; Montresor A; French M; Reithinger R; Rodari P; Bisoffi Z; Buonfrate D
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009314. PubMed ID: 33857134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
    Echazú A; Juarez M; Vargas PA; Cajal SP; Cimino RO; Heredia V; Caropresi S; Paredes G; Arias LM; Abril M; Gold S; Lammie P; Krolewiecki AJ
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006003. PubMed ID: 28991899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivermectin Treatment and Sanitation Effectively Reduce Strongyloides stercoralis Infection Risk in Rural Communities in Cambodia.
    Forrer A; Khieu V; Schindler C; Schär F; Marti H; Char MC; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004909. PubMed ID: 27548286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control programs for strongyloidiasis in areas of high endemicity: an economic analysis of different approaches.
    Buonfrate D; Zammarchi L; Bisoffi Z; Montresor A; Boccalini S
    Infect Dis Poverty; 2021 May; 10(1):76. PubMed ID: 34030741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side Benefits of Mass Drug Administration for Lymphatic Filariasis on
    Barda B; Albonico M; Buonfrate D; Ame SM; Ali S; Speich B; Keiser J
    Am J Trop Med Hyg; 2017 Sep; 97(3):681-683. PubMed ID: 28722622
    [No Abstract]   [Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
    Gandasegui J; Onwuchekwa C; Krolewiecki AJ; Doyle SR; Pullan RL; Enbiale W; Kepha S; Hatherell HA; van Lieshout L; Cambra-Pellejà M; Escola V; Muñoz J
    Lancet Infect Dis; 2022 Nov; 22(11):e341-e347. PubMed ID: 35850127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.
    Henriquez-Camacho C; Gotuzzo E; Echevarria J; White AC; Terashima A; Samalvides F; Pérez-Molina JA; Plana MN
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD007745. PubMed ID: 26778150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the health education and preventive equipment package (HEPEP) on prevention of Strongyloides stercoralis infection among rural communities in Northeast Thailand: a cluster randomized controlled trial.
    Laoraksawong P; Sanpool O; Rodpai R; Thanchomnang T; Kanarkard W; Maleewong W; Kraiklang R; Intapan PM
    BMC Public Health; 2018 Oct; 18(1):1184. PubMed ID: 30340481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
    Anselmi M; Buonfrate D; Guevara Espinoza A; Prandi R; Marquez M; Gobbo M; Montresor A; Albonico M; Racines Orbe M; Martin Moreira J; Bisoffi Z
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004150. PubMed ID: 26540412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Strongyloides in Southeast Asia: a systematic review and meta-analysis with implications for public health and sustainable control strategies.
    Chan AHE; Kusolsuk T; Watthanakulpanich D; Pakdee W; Doanh PN; Yasin AM; Dekumyoy P; Thaenkham U
    Infect Dis Poverty; 2023 Sep; 12(1):83. PubMed ID: 37705080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia.
    Khieu V; Schär F; Marti H; Sayasone S; Duong S; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2013; 7(2):e2035. PubMed ID: 23409200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Strongyloides stercoralis infection in high-risk patients in Khuzestan Province, Southwestern Iran.
    Ashiri A; Rafiei A; Beiromvand M; Khanzadeh A; Alghasi A
    Parasit Vectors; 2021 Jan; 14(1):37. PubMed ID: 33422116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.
    Buonfrate D; Salas-Coronas J; Muñoz J; Maruri BT; Rodari P; Castelli F; Zammarchi L; Bianchi L; Gobbi F; Cabezas-Fernández T; Requena-Mendez A; Godbole G; Silva R; Romero M; Chiodini PL; Bisoffi Z
    Lancet Infect Dis; 2019 Nov; 19(11):1181-1190. PubMed ID: 31558376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strongyloides stercoralis is associated with significant morbidity in rural Cambodia, including stunting in children.
    Forrer A; Khieu V; Schär F; Hattendorf J; Marti H; Neumayr A; Char MC; Hatz C; Muth S; Odermatt P
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005685. PubMed ID: 29059195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global prevalence and epidemiology of Strongyloides stercoralis in dogs: a systematic review and meta-analysis.
    Eslahi AV; Hashemipour S; Olfatifar M; Houshmand E; Hajialilo E; Mahmoudi R; Badri M; Ketzis JK
    Parasit Vectors; 2022 Jan; 15(1):21. PubMed ID: 35012614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
    Marks M; Gwyn S; Toloka H; Kositz C; Asugeni J; Asugeni R; Diau J; Kaldor JM; Romani L; Redman-MacLaren M; MacLaren D; Solomon AW; Mabey DCW; Steer AC; Martin D
    Clin Infect Dis; 2020 Dec; 71(12):3226-3228. PubMed ID: 32421762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity Associated with Chronic
    Tamarozzi F; Martello E; Giorli G; Fittipaldo A; Staffolani S; Montresor A; Bisoffi Z; Buonfrate D
    Am J Trop Med Hyg; 2019 Jun; 100(6):1305-1311. PubMed ID: 30963990
    [No Abstract]   [Full Text] [Related]  

  • 20. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.